FAKTOR-OPTIONSSCHEIN - COOPER COMPANIES Share Price

Certificat

DE000MG34UB2

Market Closed - Börse Stuttgart 12:09:44 28/05/2024 BST
7.08 EUR +1.29% Intraday chart for FAKTOR-OPTIONSSCHEIN - COOPER COMPANIES
Current month-33.33%
1 month-33.65%
Date Price Change
28/05/24 7.08 +1.29%
27/05/24 6.99 -2.65%
24/05/24 7.18 -3.10%
23/05/24 7.41 +10.93%
22/05/24 6.68 +1.67%

Delayed Quote Börse Stuttgart

Last update May 28, 2024 at 12:09 pm

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying THE COOPER COMPANIES, INC.
Issuer Morgan Stanley
WKN MG34UB
ISINDE000MG34UB2
Date issued 26/04/2024
Strike 113.9 $
Maturity Unlimited
Parity 2.44 : 1
Emission price 10
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 10.85
Lowest since issue 5.98
Spread 0.05
Spread %0.59%

Company Profile

The Cooper Companies, Inc. is a global medical device company. The Company operates through two business units: CooperVision and CooperSurgical. CooperVision is engaged in the contact lens industry. CooperVision’s products include MyDay daily disposable, MyDay daily disposable toric, MyDay Energys, MyDay multifocal, Biofinity & Biofinity XR, Biofinity Energys, Biofinity toric & Biofinity XR toric, Biofinity multifocal, Biofinity toric multifocal, clariti 1 day, clariti 1 day toric, clariti 1 day multifocal, MiSight 1 day, Avaira Vitality and Avaira Vitality toric. CooperSurgical is a fertility and women’s health company dedicated to assisting women, babies and families around the world. CooperSurgical provides a range of products and services with an emphasis on improving fertility solutions, empowering office-based care, and advancing hospital care within women’s health. CooperSurgical’s brands include Paragard, ER-Complete, Fetal Pillow, INSORB, PGT-Complete, RUMI II and others.
Sector
-
More about the company

Ratings for The Cooper Companies, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: The Cooper Companies, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
91.68 USD
Average target price
107.9 USD
Spread / Average Target
+17.68%
Consensus